Stay updated with breaking news from Eric Elenko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12-month price […]
Artia Global Partners LP purchased a new stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 99,267 shares of the company’s stock, valued at approximately $19,506,000. Karuna Therapeutics comprises about 7.4% of […]
First Light Asset Management LLC lowered its stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 1.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 164,615 shares of the company’s stock after selling 1,701 shares during the period. Karuna Therapeutics accounts for about 3.0% of First Light Asset Management LLC’s holdings, making […]
58.com reissued their maintains rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Get Rating) in a research report released on Monday morning, Benzinga reports. Several other equities research analysts have also commented on the company. HC Wainwright reduced their price objective on Karuna Therapeutics from $320.00 to $300.00 and set a buy rating for the […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its target price trimmed by JPMorgan Chase & Co. from $260.00 to $250.00 in a report issued on Monday morning, The Fly reports. A number of other brokerages have also recently issued reports on KRTX. Mizuho increased their price objective on Karuna Therapeutics from $270.00 to $274.00 in […]